Verastem, Inc. - Common Stock — Flux de trésorerie (NASDAQ:VSTM)

Afficher le graphique complet Full chart

Financials

Flux de trésorerie liés aux activités d'exploitation -33.51 M-53.5 M-63.67 M-86.46 M-104.77 M-137.51 M -150.95 M Flux de trésorerie liés aux activités d'investissement -47.36 M87 K66.19 M-44.45 M59.97 M-9.62 M — Flux de trésorerie liés aux activités de financement 69.63 M6.88 M51.78 M134.19 M54.78 M263.31 M 224.57 M Flux de trésorerie disponible -33.51 M-53.5 M-63.67 M-86.46 M-104.77 M-147.13 M -150.95 M

Verastem, Inc. - Common Stock

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

VSTM

Financials

Verastem, Inc. - Common Stock

Nouvelles

Verastem Oncology nomme Michael Bailey à son conseil d’administration

3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 5/22/26 - TipRanks.com

Cancer Stocks That Are Advancing the Future of Oncology Care

Verastem (VSTM) Loses 34.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Verastem, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:VSTM) 2026-05-09

BTIG abaisse l’objectif de cours de Verastem à 18$ après des revenus décevants

Verastem (VSTM) Reports Q1 Loss, Misses Revenue Estimates

Vectoring In On Verastem (NASDAQ:VSTM)

The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying

H.C. Wainwright réitère sa recommandation sur Verastem suite à des données d’essai durables

3 Best Stocks to Buy Today, 4/11/2026, According to Top Analysts - TipRanks.com

L’action Verastem maintient sa recommandation d’achat chez BTIG grâce à des données d’essai durables